Dicloxacillin PCD Pharma Franchise Company

Cafoli Lifecare offers a Dicloxacillin range of 5 formulations across capsules and tablets, manufactured in WHO-GMP certified facilities. Distributors serving dermatology, surgery and general practice can secure district-wise monopoly franchise rights for this anti-staphylococcal penicillin with full promotional support.

What is Dicloxacillin?

Dicloxacillin is a penicillinase-resistant (anti-staphylococcal) penicillin antibiotic. It resists breakdown by staphylococcal beta-lactamase, making it a targeted choice for infections caused by penicillin-resistant Staphylococcus aureus, especially of the skin and soft tissue. Reference: PubChem - Dicloxacillin.

Available Forms

The Cafoli Dicloxacillin portfolio includes oral Capsules and Tablets, including amoxicillin-dicloxacillin combinations. Contact us for current pack presentations and combinations.

Therapeutic Applications

Dicloxacillin is prescribed for staphylococcal skin and soft-tissue infections such as boils, abscesses, cellulitis, infected wounds and mastitis, and for other penicillinase-producing staphylococcal infections. Prescribers include dermatologists, surgeons, physicians and general practitioners.

Why Dicloxacillin is a High-Potential Molecule for Distributors

Staphylococcal skin and soft-tissue infections are extremely common in India, and dicloxacillin - alone or with amoxicillin - is a routine first choice for boils, abscesses and infected wounds. Its steady, everyday use in derma and surgical practice gives distributors reliable, high-frequency antibiotic volume.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Dicloxacillin
2. MedlinePlus: Dicloxacillin
3. PubMed: dicloxacillin in staphylococcal infection